Author:
Li Guo-Dong,Bi Rui,Zhang Deng-Feng,Xu Min,Luo Rongcan,Wang Dong,Fang Yiru,Li Tao,Zhang Chen,Yao Yong-Gang
Funder
Strategic Priority Research Program (B) of the Chinese Academy of Sciences
Bureau of Frontier Sciences and Education, Chinese Academy of Sciences
Alzheimer's Disease Neuroimaging Initiative (ADNI)
National Institutes of Health
DOD ADNI
Department of Defense
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
BioClinica, Inc
Biogen Idec Inc
Bristol-Myers Squibb Company
Eisai Inc
Elan Pharmaceuticals, Inc
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Genentech
GE Healthcare
Innogenetics, N.V.
IXICO Ltd
Janssen Alzheimer Immunotherapy Research & Development, LLC
Johnson & Johnson Pharmaceutical Research & Development LLC
Medpace, Inc
Merck & Co, Inc
Meso Scale Diagnostics, LLC
NeuroRx Research
Novartis Pharmaceuticals Corporation
Pfizer Inc
Piramal Imaging
Servier
Synarc Inc
Takeda Pharmaceutical Company
Canadian Institutes of Health Research
Northern California Institute for Research and Education
Subject
Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience